Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Ranked as the most influential EP journal with a record-breaking Impact Factor of 6.1 in 2018, EP Europace provides an avenue of communication for top quality, original European and international scientific work and reviews in the fields of arrhythmias, pacing and cellular electrophysiology.
Statements, positions, and policies from EHRA, its committees and its constituent bodies
This apps contains the principal messages of our scientific documents, providing highlights in a concise, accessible format.
A number of important registries and trials are ongoing under the European Observational Research Programme (EORP) with EHRA being represented by the Chair of its Scientific Initiatives Committee.
"Translating guidelines into practice Surveys" give a picture of daily EP practice in Europe with particular focus on the implementation of the arrhythmia-related ESC guidelines in European countries.
European Sudden Cardiac Arrest network: towards prevention, education, new effective treatment.
CATCH ME: Characterising atrial fibrillation by translating its causes into health modifiers in the elderly.
Suggested reading and key references in specific areas of arrhythmias and heart rhythm management
Novel Oral Anticoagulants for Atrial Fibrillation: Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Case-based learning with multiple choice questions:
• pacemaker, ICD, and CRT troubleshooting
CardioScape outlines the current CVD research and innovation landscape across Europe.
A unique database on healthcare systems, as well as provision- and care services in cardiovascular medicine. It can serve as a European tool of comparative analysis to identify best practices and trends.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.